Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 1;12(10):235.
doi: 10.3390/diseases12100235.

Complete Androgen Insensitivity Syndrome in a Young Girl with Primary Amenorrhea and Suspected Delayed Puberty: A Case-Based Review of Clinical Management, Surgical Follow-Up, and Oncological Risk

Affiliations
Review

Complete Androgen Insensitivity Syndrome in a Young Girl with Primary Amenorrhea and Suspected Delayed Puberty: A Case-Based Review of Clinical Management, Surgical Follow-Up, and Oncological Risk

Barbara Fraccascia et al. Diseases. .

Abstract

Background: Complete androgen insensitivity syndrome (CAIS) is a rare disorder of sex development characterized by 46,XY karyotype and testes, yet presenting with a complete female phenotype, which is related to mutations in the androgen receptor (AR) gene. Case presentation: We herein present the case of a 14-year-old adolescent with primary amenorrhea and suspected delayed puberty whose diagnostic journey led to the identification of CAIS through the demonstration of a novel AR variant (c.159_207del). Case-based review: Our report encompasses the complexity of CAIS management, focusing on the risk of malignancy, surveillance options, hormone replacement therapy, timing of an eventual gonadectomy, and the psychosocial impact of such a diagnosis. An algorithm has been formulated for the management of CAIS starting in adolescence, highlighting the conservative approach for those patients unwilling to undergo gonadectomy. Conclusions: Primary amenorrhea and delay in puberty development may provide clues, ultimately leading to a diagnosis of CAIS. This review emphasizes the cruciality of a multidisciplinary approach in managing patients with CAIS, needing for an individualized care to optimize the overall outcome.

Keywords: complete androgen insensitivity syndrome; disorders of sex development; pediatric endocrinology; personalized medicine; sexual development.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Proposal for an algorithm for the management of patients with complete androgen insensitivity syndrome. * OCT3/4: Octamer-binding transcription factor 3/4.

References

    1. Hughes I.A., Houk C., Ahmed S.F., LWPES/ESPE Consensus Group Consensus statement on the management of intersex disorders.Consensus statement on management of intersex disorders. Arch. Dis. Child. 2006;91:554–563. doi: 10.1136/adc.2006.098319. - DOI - PMC - PubMed
    1. Cools M., Nordenström A., Robeva R., Hall J., Westerveld P., Flück C., Köhler B., Berra M., Springer A., Schweizer K., et al. Caring for individuals with a difference of sex development (DSD): A Consensus Statement. Nat. Rev. Endocrinol. 2018;14:415–429. doi: 10.1038/s41574-018-0010-8. - DOI - PMC - PubMed
    1. Lanciotti L., Cofini M., Leonardi A., Bertozzi M., Penta L., Esposito S. Different Clinical Presentations and Management in Complete Androgen Insensitivity Syndrome (CAIS) Int. J. Environ. Res. Public Health. 2019;16:1268. doi: 10.3390/ijerph16071268. - DOI - PMC - PubMed
    1. Deans R., Creighton S.M., Liao L.M., Conway G.S. Timing of gonadectomy in adult women with complete androgen insensitivity syndrome (CAIS): Patient preferences and clinical evidence. Clin. Endocrinol. 2012;76:894–898. doi: 10.1111/j.1365-2265.2012.04330.x. - DOI - PubMed
    1. World Health Organization Reference values for human chorionic gonadotropin (hCG) and human menopausal gonadotropin (HMG) Int. J. Gynaecol. Obstet. 1999;67:119–129. - PubMed

LinkOut - more resources